Paper Tigers Or Paper Bullets? FDA Curbs Repeat Warning Letters, Violations
This article was originally published in The Gray Sheet
Executive Summary
Enforcement policies under way within FDA's Office of the Chief Counsel could eliminate the practice of issuing multiple compliance warning letters, according to agency officials